Les Laboratoires Servier SAS - Company Profile
Powered by 
All the data and insights you need on Les Laboratoires Servier SAS in one report.
$295
- Save hours of research time and resources with
our up-to-date Les Laboratoires Servier SAS Strategy Report
- Understand Les Laboratoires Servier SAS position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Les Laboratoires Servier SAS’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 01 Apr 2024 | EGIS Pharmaceuticals Plc Enters Phase I Clinical Trial Agreement with X7 Clinical Research Center for (sacubitril + valsartan) (GDCT0517388) | Contract Service Agreement |
EGIS Pharmaceuticals Plc
|
X7 Clinical Research Center
|
| 05 Jan 2024 | Les Laboratoires Servier Expands Licensing Agreement with Base4 Biotech | Licensing Agreement |
Les Laboratoires Servier SAS
|
Base4 Biotechnology Inc
|
| 21 Dec 2023 | CStone Sells Exclusive Rights to TIBSOVO in Greater China and Singapore to Servier | Asset Transaction |
Les Laboratoires Servier SAS
|
CStone Pharmaceuticals Co Ltd |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer